Cargando…
Prevalence and impact of comorbid obstructive sleep apnoea in diffuse parenchymal lung diseases
OBJECTIVE: Obstructive sleep apnea (OSA) are increasingly recognized as important features in diffuse parenchymal lung diseases (DPLDs) with differed prevalence and impact reported. The aim of this study is to systematically review the prevalence of comorbid OSA and characterize its impact on clinic...
Autores principales: | Li, Diandian, Wang, Bo, Liu, Yi, Wang, Haohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877600/ https://www.ncbi.nlm.nih.gov/pubmed/33571266 http://dx.doi.org/10.1371/journal.pone.0246878 |
Ejemplares similares
-
Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease—characterization and treatment compliance assessment
por: Cardoso, Ana Verónica, et al.
Publicado: (2018) -
Bidirectional relationships of comorbidity with obstructive sleep apnoea
por: Gleeson, Margaret, et al.
Publicado: (2022) -
Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea–COPD overlap syndrome: data from the European Sleep Apnoea Database
por: van Zeller, Mafalda, et al.
Publicado: (2023) -
Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome
por: FUSETTI, M., et al.
Publicado: (2012) -
Impact of rail medical standard on obstructive sleep apnoea prevalence
por: Colquhoun, C. P., et al.
Publicado: (2016)